JPRN-UMIN000019323已完成3 期
Efficacy and Safety of the Tadarafil Monotherapy or Coadministration of Tadarafil with Dutasteride in Men with Benign Prostatic Hyperplasia: A Phase III Randomized Open-Label Study - TMCTD study
Department of Urology Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital0 个研究点目标入组 200 人开始时间: 2015年11月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Prostate cancer 2) Neurogenic bladder 3) no administration of drugs for overactive bladder and BPH exclude a1-blocker 4) no administration of Dutasteride, Finasteride, anti-androgen, and testosterone within 6 months 5) no administration of PDE5 inhibitors 6) contraindication of Tadarafil 7) contraindication of Dutasteride
研究者
相似试验
已完成
不适用
The efficacy and safety of Tadarafil for treatment of nocturia and sleep qualityJPRN-UMIN000018292Fujita Health University50
已完成
不适用
The persistence of tadalafil monotherapy and the reasons for withdrawal from treatment of treatment-naive patients with benign prostatic hyperplasia in the real-world clinical settingBenign prostatic hyperplasiaJPRN-UMIN000032766Hokkaido Prefectural Esashi Hospital113
尚未招募
4 期
A study to compare the beneficial effect and safety of tadalafil compared to sildenafil in pulmonary hypertensive patients due to lung diseaseCTRI/2024/06/069470Midhun Sakravarthy J
已完成
不适用
Study of the efficacy and safety of tadalafil and imidafenacin combination therapy for benign prostatic hyperplasia with overactive bladderBenign prostatic hyperplasia patients with overactive bladder despite tadalafil treatmentJPRN-UMIN000021959Kawahara Clinic30
招募中
不适用
Comparison of tadalafil monotherapy and its combination with mirabegron for efficacy in the treatment of storage symptoms with benign prostatic hyperplasiaBenign prostatic hyperplasiaJPRN-UMIN000030560Division of Urology, Department of Surgery, Tottori University Faculty of Medicine120